Clinical Trial Update: Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 study assessing the dose–response of hippocampal stimulation using interleaved TMS-fMRI in amnestic mild cognitive impairment; the trial is completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amnestic Mild Cognitive Impairment
• Cognitive Impairment

Drugs mentioned

• Interleaved TMS-fMRI (transcranial magnetic stimulation (TMS))

Snippet

Sponsor: University of Arizona | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2025-07-29